Drug Discovery - Medicine.net

Drug Discovery

Sub Categories on Drug Discovery

{{items.name}}

Latest Articles

How brain fluid dynamics drive cancer spread—and ways to fight back

How brain fluid dynamics drive cancer spread—and ways to fight back

Updated on: October 03,2025

How brain fluid dynamics drive cancer spread—and ways to fight back

How brain fluid dynamics drive cancer spread—and ways to fight back

Updated on:October 03,2025

Video-assisted thoracoscopy surgery reduces mortality by 21% compared to lobectomy, meta-analysis suggests

Video-assisted thoracoscopy surgery reduces mortality by 21% compared to lobectomy, meta-analysis suggests

Updated on: October 03,2025

Video-assisted thoracoscopy surgery reduces mortality by 21% compared to lobectomy, meta-analysis suggests

Video-assisted thoracoscopy surgery reduces mortality by 21% compared to lobectomy, meta-analysis suggests

Updated on:October 03,2025

Simultaneous cell isolation technology shows clinical feasibility for increased accuracy in cancer diagnostics

Simultaneous cell isolation technology shows clinical feasibility for increased accuracy in cancer diagnostics

Updated on: October 03,2025

Simultaneous cell isolation technology shows clinical feasibility for increased accuracy in cancer diagnostics

Simultaneous cell isolation technology shows clinical feasibility for increased accuracy in cancer diagnostics

Updated on:October 03,2025

Antioxidant shield for T cell telomeres shows promise against tumor-induced exhaustion

Antioxidant shield for T cell telomeres shows promise against tumor-induced exhaustion

Updated on: October 03,2025

Antioxidant shield for T cell telomeres shows promise against tumor-induced exhaustion

Antioxidant shield for T cell telomeres shows promise against tumor-induced exhaustion

Updated on:October 03,2025

Study highlights communication gaps and need for shared decision-making in lung cancer diagnosis

Study highlights communication gaps and need for shared decision-making in lung cancer diagnosis

Updated on: October 03,2025

Study highlights communication gaps and need for shared decision-making in lung cancer diagnosis

Study highlights communication gaps and need for shared decision-making in lung cancer diagnosis

Updated on:October 03,2025

Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR-mutated NSCLC

Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR-mutated NSCLC

Updated on: October 03,2025

Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR-mutated NSCLC

Subcutaneous amivantamab every 4 weeks plus lazertinib shows high response rate in EGFR-mutated NSCLC

Updated on:October 03,2025

Clinical study deepens understanding of mesothelioma, opens the door to potential treatment options

Clinical study deepens understanding of mesothelioma, opens the door to potential treatment options

Updated on: October 03,2025

Clinical study deepens understanding of mesothelioma, opens the door to potential treatment options

Clinical study deepens understanding of mesothelioma, opens the door to potential treatment options

Updated on:October 03,2025

$Hypofractionated radiotherapy with chemotherapy offers comparable survival, lower toxicity in LS-SCLC$

Hypofractionated radiotherapy with chemotherapy offers comparable survival, lower toxicity in LS-SCLC

Updated on: October 03,2025

$Hypofractionated radiotherapy with chemotherapy offers comparable survival, lower toxicity in LS-SCLC$

Hypofractionated radiotherapy with chemotherapy offers comparable survival, lower toxicity in LS-SCLC

Updated on:October 03,2025

New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer

New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer

Updated on: October 03,2025

New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer

New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer

Updated on:October 03,2025

Ivonescimab + chemotherapy improves progression-free survival in patients with EGFR+ NSCLC

Ivonescimab + chemotherapy improves progression-free survival in patients with EGFR+ NSCLC

Updated on: October 03,2025

Ivonescimab + chemotherapy improves progression-free survival in patients with EGFR+ NSCLC

Ivonescimab + chemotherapy improves progression-free survival in patients with EGFR+ NSCLC

Updated on:October 03,2025

Categories

Allergy&Clinical immunology

Anesthesiology & Pain

Cardiovascular Diseases

Diabetes & Endocrinology

Emergency Medicine & Critical Care

Family Medicine

Gastroenterology

General Surgery

Hematology&Oncology

Infectious Diseases

Nephrology & Urology

Orthopedics & Sports medicine

Plastic Surgery

Psychiatry & Mental Health

Public Health & Prevention